 With me today are Damien McDevitt, our Chief Executive Officer; Kyle Jenne, our Chief Commercial Officer; and Michael Price, our Chief Financial Officer. As a reminder, this conference call includes forward-looking statements regarding the financial outlook for Akcea, Akceas business and the therapeutic and commercial potential of Akceas products and development. 